SEARCH

SEARCH BY CITATION

References

  • 1
    Motzer RJ, Russo P, Nanus DM, Berg WJ. Renal cell carcinoma. Curr. Probl. Cancer 1997; 21: 185232.
  • 2
    Jinzaki M, McTavish JD, Zou KH, Judy PF, Silverman SG. Evaluation of small (≤ 3 cm) renal masses with MDCT: benefits of thin overlapping reconstructions. AJR Am. J. Roentgenol. 2004; 183: 2238.
  • 3
    Walther MM, Choyke PL, Glenn G et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J. Urol. 1999; 161: 14759.
  • 4
    Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up. J. Urol. 2000; 163: 4425.
  • 5
    Rehman J, Landman J, Lee D et al. Needle-based ablation of renal parenchyma using microwave, cryoablation, impedance- and temperature-based monopolar and bipolar radiofrequency, and liquid and gel chemoablation: laboratory studies and review of the literature. J. Endourol. 2004; 18: 83104.
  • 6
    Kohrmann KU, Michel MS, Steidler A, Marlinghaus E, Kraut O, Alken P. Technical characterization of an ultrasound source for noninvasive thermoablation by high-intensity focused ultrasound. BJU Int. 2002; 90: 24852.
  • 7
    Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am. J. Roentgenol. 2000; 174: 32331.
  • 8
    Livraghi T. Treatment of hepatocellular carcinoma by interventional methods. Eur. Radiol. 2001; 11: 220719.
  • 9
    Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor Ablation with Radiofrequency Energy. Radiology 2000; 217: 63346.
  • 10
    Gervais DA, McGovern FJ, Wood BJ, Goldberg SN, McDougal WS, Mueller PR. Radio-frequency ablation of renal cell carcinoma: early clinical experience. Radiology 2000; 217: 66572.
  • 11
    Pavlovich CP, Walther MM, Choyke PL et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J. Urol. 2002; 167: 1015.
  • 12
    Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am. J. Roentgenol. 2005; 185: 6471.
  • 13
    Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. AJR Am. J. Roentgenol. 2005; 185: 7280.
  • 14
    Veltri A, De Fazio G, Malfitana V. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur. Radiol. 2004; 14: 230310.
  • 15
    Su LM, Jarrett TW, Chan DY, Kavoussi LR, Solomon SB. Percutaneous computed tomography-guided radiofrequency ablation of renal masses in high surgical risk patients: preliminary results. Urology 2003; 61: 2633.
  • 16
    Ukimura O, Kawauchi A, Fujito A et al. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk. Int. J. Urol. 2004; 11: 10517.
  • 17
    Johnson DB, Saboorian MH, Duchene DA, Ogan K, Cadeddu JA. Nephrectomy after radiofrequency ablation-induced ureteropelvic junction obstruction: potential complication and long-term assessment of ablation adequacy. Urology 2003; 62: 3512.
  • 18
    Varkarakis IM, Allaf ME, Inagaki T et al. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup. J. Urol. 2005; 174: 45660.
  • 19
    de Jode MG, Vale JA, Gedroyc WM. MR-guided laser thermoablation of inoperable renal tumors in an open-configuration interventional MR scanner: preliminary clinical experience in three cases. J. Magn. Reson. Imaging 1999; 10: 5459.
  • 20
    Gill IS. Minimally invasive nephron-sparing surgery. Urol. Clin. North Am. 2003; 30: 55179.
  • 21
    Brouwers AH, Mulders PF, de Mulder PH et al. Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma. J. Clin. Oncol. 2005; 23: 65408.
  • 22
    Goldberg SN, Gazelle GS, Dawson SL, Rittman WJ, Mueller PR, Rosenthal DI. Tissue ablation with radiofrequency using multiprobe arrays. Acad. Radiol. 1995; 2: 6704.
  • 23
    Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003; 226: 41724.
  • 24
    Zlotta AR, Wildschutz T, Raviv G et al. Radiofrequency interstitial tumor ablation (RITA) is a possible new modality for treatment of renal cancer: ex vivo and in vivo experience. J. Endourol. 1997; 11: 2518.
  • 25
    Michaels MJ, Rhee HK, Mourtzinos AP, Summerhayes IC, Silverman ML, Libertino JA. Incomplete renal tumor destruction using radio frequency interstitial ablation. J. Urol. 2002; 168: 24069.
  • 26
    Rendon RA, Kachura JR, Sweet JM et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J. Urol. 2002; 167: 158792.
  • 27
    Nakada SY, Jerde TJ, Warner TF, Lee FT Jr. Comparison of radiofrequency ablation, cryoablation, and nephrectomy in treating implanted VX-2 carcinoma in rabbit kidneys. J. Endourol. 2004; 18: 5016.
  • 28
    Johnson DB, Taylor GD, Lotan Y, Sagalowsky AI, Koenemann KS, Cadeddu JA. The effects of radio frequency ablation on renal function and blood pressure. J. Urol. 2003; 170: 22346.
  • 29
    Nakada SY, Jerde TJ, Warner TF et al. Bipolar radiofrequency ablation of the kidney: comparison with monopolar radiofrequency ablation. J. Endourol. 2003; 17: 92733.